MyImmune Corporation
PrivateLast Round
Accelerator
Jul 1, 2026
Momentum
Top 10%
of companies Caplight tracks
Company Overview
MyImmune Corporation is a biotechnology company that utilizes an artificial intelligence platform to analyze adaptive immune receptor data for disease diagnosis and therapeutic development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MyImmune Corporation Comparables
Compare MyImmune Corporation with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Etcembly | 77% | |
| iRepertoire, Inc. | 76% | |
| Adaptive Biotechnologies | 73% | |
MyImmune Corporation Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jul 1, 2026 | ||||
| Pre Seed | Oct 23, 2024 |
Key People
Founding team and executive leadership
MyImmune Corporation Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MassChallenge Israel | Accelerator |
| Osaka University Venture Capital Co., Ltd. | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 1, 2026
Received funding from MassChallenge Israel.
- Jan 21, 2026
Monthly visitors grew 197% MoM.
MyImmune Corporation Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about MyImmune Corporation's valuation, stock price, and market status.